Comparative safety of antiepileptic drugs during pregnancy.

PubWeight™: 3.32‹?› | Rank: Top 1%

🔗 View Article (PMID 22551726)

Published in Neurology on May 02, 2012

Authors

S Hernández-Díaz1, C R Smith, A Shen, R Mittendorf, W A Hauser, M Yerby, L B Holmes, North American AED Pregnancy Registry, North American AED Pregnancy Registry

Author Affiliations

1: Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. shernan@hsph.harvard.edu

Articles citing this

Mortality and Morbidity During Delivery Hospitalization Among Pregnant Women With Epilepsy in the United States. JAMA Neurol (2015) 2.07

Antiepileptic drug use by pregnant women enrolled in Florida Medicaid. Neurology (2015) 1.41

Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies. Neurology (2016) 1.40

A comparison of active adverse event surveillance systems worldwide. Drug Saf (2014) 1.19

Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study. BMJ (2015) 1.10

Comparative safety of antiepileptic drugs during pregnancy. Neurology (2013) 1.06

The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel) (2013) 0.92

Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav (2013) 0.86

Mood stabilizers in pregnancy and lactation. Indian J Psychiatry (2015) 0.83

Levetiracetam: more evidence of safety in pregnancy. Epilepsy Curr (2013) 0.82

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION. Ann Clin Transl Neurol (2014) 0.81

A cautionary note about estimating effects of secondary exposures in cohort studies. Am J Epidemiol (2015) 0.80

Management of epilepsy during pregnancy: an update. Ther Adv Neurol Disord (2015) 0.80

Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study. Neurology (2013) 0.79

Alteration of bioelectrically-controlled processes in the embryo: a teratogenic mechanism for anticonvulsants. Reprod Toxicol (2014) 0.78

Effects of antiepileptic drug monotherapy on one-carbon metabolism and DNA methylation in patients with epilepsy. PLoS One (2015) 0.78

Carbamazepine clearance and seizure stability during pregnancy. Epilepsy Behav (2014) 0.78

Increased homocysteine levels in valproate-treated patients with epilepsy: a meta-analysis. BMJ Open (2014) 0.77

Pharmacogenetic evaluation of ABCB1, Cyp2C9, Cyp2C19 and methylene tetrahydrofolate reductase polymorphisms in teratogenicity of anti-epileptic drugs in women with epilepsy. Ann Indian Acad Neurol (2014) 0.77

Restless legs syndrome and pregnancy: a review. Parkinsonism Relat Disord (2014) 0.77

Lipid peroxidation, detoxification capacity, and genome damage in mice after transplacental exposure to pharmaceutical drugs. Braz J Med Biol Res (2013) 0.76

Women with epilepsy. Funct Neurol (2016) 0.75

An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes. J Pediatr Genet (2015) 0.75

Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges. Drug Healthc Patient Saf (2014) 0.75

Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy Registry. Pharmacoepidemiol Drug Saf (2014) 0.75

Fetal Valproate Syndrome with Limb Defects: An Indian Case Report. Case Rep Pediatr (2016) 0.75

Breast is still best: no harmful effects of breastfeeding in women taking antiepileptic drugs. Epilepsy Curr (2015) 0.75

Congenital Anomalies in Children of Mothers Taking Antiepileptic Drugs with and without Periconceptional High Dose Folic Acid Use: A Population-Based Cohort Study. PLoS One (2015) 0.75

Are newer antiepileptic drugs associated with improved safety in pregnancy compared to older antiepileptic drugs? Epilepsy Curr (2013) 0.75

Topiramate, zonisamide and small for gestational age: maternal factors, timing of exposure and baby fat. Epilepsy Curr (2014) 0.75

Evaluation of medication-mediated effects in pharmacoepidemiology. Epidemiology (2016) 0.75

The experiences of prepregnancy care for women with type 2 diabetes mellitus: a meta-synthesis. Int J Womens Health (2016) 0.75

Are epidemiological approaches suitable to study risk/preventive factors for human birth defects? Curr Epidemiol Rep (2015) 0.75

The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review. Drugs Real World Outcomes (2016) 0.75

Laser light scan analysis of the "anticonvulsant face". Birth Defects Res A Clin Mol Teratol (2014) 0.75

Old versus New: Why Do We Need New Antiepileptic Drugs? J Epilepsy Res (2014) 0.75

Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med (2017) 0.75

Author response. Neurology (2013) 0.75

Use of Antiepileptic Drugs During Pregnancy: Evolving Concepts. Neurotherapeutics (2016) 0.75

Facial Dysmorphism: An Unreported Teratogenicity with Levetiracetam. J Clin Diagn Res (2017) 0.75

Congenital Malformations and Consequential Epidemiology. Curr Epidemiol Rep (2015) 0.75

Epilepsy during pregnancy: focus on management strategies. Int J Womens Health (2016) 0.75

Effects of lacosamide "a novel antiepileptic drug" in the early stages of chicken embryo development. Childs Nerv Syst (2016) 0.75

Exposure to Sodium Valproate during Pregnancy: Facial Features and Signs of Autism. Birth Defects Res (2017) 0.75

Recent advances in epilepsy. J Neurol (2017) 0.75

Articles by these authors

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis (1987) 5.63

Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol (1998) 5.54

Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med (1994) 5.37

Remission of seizures and relapse in patients with epilepsy. Epilepsia (1979) 4.17

Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke (2001) 4.07

Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nat Genet (1997) 3.91

Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet (1997) 3.77

Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet (1989) 3.74

Physician knowledge, attitudes, and behavior related to reporting adverse drug events. Arch Intern Med (1988) 3.74

The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia (1975) 3.67

Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health (1983) 3.33

Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med (1987) 3.21

A population-based study of seizures after traumatic brain injuries. N Engl J Med (1998) 3.12

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med (1994) 3.09

Pregnancy termination in relation to risk of breast cancer. JAMA (1996) 3.04

The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology (1997) 2.96

Reporting accuracy among mothers of malformed and nonmalformed infants. Am J Epidemiol (1989) 2.88

Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology (2005) 2.80

Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet (1995) 2.72

Etiologic heterogeneity of neural-tube defects. N Engl J Med (1976) 2.71

Homeless and housed families in Los Angeles: a study comparing demographic, economic, and family function characteristics. Am J Public Health (1990) 2.71

Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke (1998) 2.70

A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology (1996) 2.69

The protective effect of moderate alcohol consumption on ischemic stroke. JAMA (1999) 2.68

Controlled comparison of amikacin and gentamicin. N Engl J Med (1977) 2.62

Long-term mortality after a first episode of status epilepticus. Neurology (2002) 2.60

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology (2009) 2.58

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med (1984) 2.54

Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med (1980) 2.51

The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol (1988) 2.51

Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet (1998) 2.50

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis (1984) 2.44

Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med (1995) 2.33

The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology (2005) 2.32

Do mussels take wooden steps to deep-sea vents? Nature (2000) 2.32

Under-recognition of prenatal alcohol effects in infants of known alcohol abusing women. J Pediatr (1999) 2.25

Seizure recurrence after a first unprovoked seizure. N Engl J Med (1982) 2.23

Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry (2008) 2.22

Genital abnormalities in females with Bardet-Biedl syndrome. Am J Med Genet (1995) 2.22

Cysticercosis and epilepsy: a critical review. Epilepsia (1998) 2.21

Moderate caffeine use and the risk of spontaneous abortion and intrauterine growth retardation. JAMA (1993) 2.20

Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology (2001) 2.19

Hypertension and the risk of new-onset unprovoked seizures. Neurology (1993) 2.19

Aniridia-Wilms' tumor association: evidence for specific deletion of 11p13. Cytogenet Cell Genet (1979) 2.18

The incidence and significance of birthmarks in a cohort of 4,641 newborns. Pediatr Dermatol (1983) 2.16

Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside. Lancet (1978) 2.10

High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol (1999) 2.08

Unusual sequences in the murine immunoglobulin mu-delta heavy-chain region. Nature (1984) 2.08

Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota. Neurology (2011) 2.06

Major depression is a risk factor for seizures in older adults. Ann Neurol (2000) 2.05

Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology (2008) 2.04

How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world. Mov Disord (1998) 2.03

Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke (1997) 2.00

A prospective study of recurrent febrile seizures. N Engl J Med (1992) 1.99

The prenatal detection of significant alcohol exposure with maternal blood markers. J Pediatr (1998) 1.96

Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg (1998) 1.95

Experimental verocytotoxemia in rabbits. Infect Immun (1992) 1.94

Semistructured interview for seizure classification: agreement with physicians' diagnoses. Epilepsia (1990) 1.93

Malformations due to presumed spontaneous mutations in newborn infants. N Engl J Med (1989) 1.86

Predictive value of minor anomalies. I. Association with major malformations. J Pediatr (1987) 1.85

Higher risk of seizures in offspring of mothers than of fathers with epilepsy. Am J Hum Genet (1988) 1.84

Bronchocentric mycosis occurring in transplant recipients. Chest (1989) 1.84

Robotic mitral valve surgery: a United States multicenter trial. J Thorac Cardiovasc Surg (2005) 1.77

Vaginal spermicides and congenital disorders. JAMA (1981) 1.74

Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis (1992) 1.73

Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology (1998) 1.72

Reliability of seizure classification using a semistructured interview. Neurology (1993) 1.71

Driving and epilepsy. A review and reappraisal. JAMA (1991) 1.69

LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology (2004) 1.67

Influence of hypothermia, barbiturate therapy, and intracranial pressure monitoring on morbidity and mortality after near-drowning. Crit Care Med (1986) 1.66

Genetic counseling for the older pregnant woman: new data and questions. N Engl J Med (1978) 1.66

Predictors of disease course in patients with probable Alzheimer's disease. Neurology (1987) 1.66

The incidence of genetic disease in a University hospital population. Am J Hum Genet (1973) 1.66

The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics (1996) 1.65

Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg (2000) 1.65

Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino) (1997) 1.64

Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg (1995) 1.63

Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann Neurol (1994) 1.63

Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg (1998) 1.63

Misclassification in epidemiologic studies of adverse drug reactions using large managerial data bases. Am J Prev Med (1988) 1.62

The risk of epilepsy following febrile convulsions. Neurology (1979) 1.61

Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology (1992) 1.61

Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol (1995) 1.59

Clinical variability within Brachmann-de Lange syndrome: a proposed classification system. Am J Med Genet (1993) 1.59

Classification of partial seizure symptoms in genetic studies of the epilepsies. Neurology (2006) 1.59

Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg (1998) 1.58

Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med (1984) 1.57

Mortality in patients with epilepsy. Epilepsia (1980) 1.56

Pressure sores among hospitalized patients. Ann Intern Med (1986) 1.56

Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol (2000) 1.56

Neonatal circumcision. Randomized trial of a sucrose pacifier for pain control. Arch Pediatr Adolesc Med (1998) 1.55

A new human immunoglobulin VH family preferentially rearranged in immature B-cell tumours. Nature (1988) 1.55

Epidemiology of epilepsy. Adv Neurol (1978) 1.54

A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology (1997) 1.54

Seizures and myoclonus in patients with Alzheimer's disease. Neurology (1986) 1.53

Relationship of cesarean delivery to lower birth weight-specific neonatal mortality in singleton breech infants in the United States. Obstet Gynecol (1998) 1.53

Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis (1984) 1.52

Population-based study of seizure disorders after cerebral infarction. Neurology (1996) 1.52

Need for inclusion and exclusion criteria for the structural abnormalities recorded in children born from exposed pregnancies. Teratology (1999) 1.52